First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: Pooled and subgroup analyses of data from 2447 patients

  1. Miles, D.W.
  2. Diéras, V.
  3. Cortés, J.
  4. Duenne, A.-A.
  5. Yi, J.
  6. O'Shaughnessy, J.
Aldizkaria:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Argitalpen urtea: 2013

Alea: 24

Zenbakia: 11

Orrialdeak: 2773-2780

Mota: Artikulua

DOI: 10.1093/ANNONC/MDT276 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus